Bank of New York Mellon Corp boosted its holdings in shares of Tempus AI, Inc. (NASDAQ:TEM – Free Report) by 281.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 232,741 shares of the company’s stock after acquiring an additional 171,776 shares during the period. Bank of New York Mellon Corp owned 0.13% of Tempus AI worth $14,788,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of TEM. ARK Investment Management LLC lifted its holdings in shares of Tempus AI by 35.9% during the first quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company’s stock valued at $361,867,000 after purchasing an additional 1,981,755 shares during the last quarter. Vanguard Group Inc. raised its stake in Tempus AI by 6,247.5% during the first quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company’s stock valued at $289,204,000 after buying an additional 5,900,668 shares during the last quarter. Nikko Asset Management Americas Inc. boosted its holdings in Tempus AI by 31.5% in the first quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company’s stock worth $205,401,000 after acquiring an additional 1,021,460 shares in the last quarter. CloudAlpha Capital Management Limited Hong Kong purchased a new stake in shares of Tempus AI in the first quarter worth $34,119,000. Finally, KADENSA CAPITAL Ltd purchased a new stake in shares of Tempus AI in the first quarter worth $22,130,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.
Tempus AI Stock Performance
Shares of TEM stock opened at $66.39 on Tuesday. The company has a quick ratio of 3.12, a current ratio of 3.28 and a debt-to-equity ratio of 2.45. The company has a 50 day moving average price of $84.88 and a 200-day moving average price of $71.87. Tempus AI, Inc. has a 52 week low of $31.36 and a 52 week high of $104.32. The firm has a market capitalization of $11.81 billion, a PE ratio of -55.79 and a beta of 4.86.
Analysts Set New Price Targets
Several research firms have recently issued reports on TEM. Guggenheim lifted their price target on Tempus AI from $80.00 to $95.00 and gave the stock a “buy” rating in a research report on Friday, September 26th. Morgan Stanley lifted their target price on shares of Tempus AI from $68.00 to $80.00 and gave the stock an “overweight” rating in a report on Tuesday, November 11th. Needham & Company LLC increased their price target on shares of Tempus AI from $70.00 to $100.00 and gave the company a “buy” rating in a report on Wednesday, November 5th. Weiss Ratings reissued a “sell (d-)” rating on shares of Tempus AI in a research report on Wednesday, October 8th. Finally, Piper Sandler lowered their price objective on Tempus AI from $105.00 to $80.00 and set a “neutral” rating on the stock in a research report on Tuesday, November 11th. Seven investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $80.00.
Read Our Latest Analysis on TEM
Insider Transactions at Tempus AI
In related news, CEO Eric P. Lefkofsky sold 332,500 shares of Tempus AI stock in a transaction on Thursday, September 25th. The stock was sold at an average price of $76.56, for a total value of $25,456,200.00. Following the completion of the sale, the chief executive officer owned 9,141,032 shares of the company’s stock, valued at $699,837,409.92. The trade was a 3.51% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, COO Ryan Fukushima sold 5,000 shares of the stock in a transaction dated Monday, October 6th. The shares were sold at an average price of $92.32, for a total value of $461,600.00. Following the completion of the transaction, the chief operating officer directly owned 130,000 shares in the company, valued at approximately $12,001,600. This represents a 3.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 1,007,870 shares of company stock worth $80,663,575 in the last ninety days. Insiders own 26.27% of the company’s stock.
About Tempus AI
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
See Also
- Five stocks we like better than Tempus AI
- What is Insider Trading? What You Can Learn from Insider Trading
- Whirlpool’s Worst May Be Over—Upside Opportunity Ahead
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- These 3 Beaten-Down Stocks Could Be Your Best Buying Opportunity This Quarter
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- How Does D-Wave Stack Up to Quantum Rivals After Earnings Season?
Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM – Free Report).
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.
